Intervention

Nicotinamide Riboside

ClinicalTrials.gov intervention label

Clinical trials12
Recruiting3
Common conditions20
Lead sponsors shown8

Clinical trials

12 shown
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma PatientsNCT06991712 · 2025-05-19
RECRUITING
Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic RateNCT06044935 · 2024-01-08
RECRUITING
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer PatientsNCT05732051 · 2023-03-16
RECRUITING
N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's DiseaseNCT05589766 · 2023-01-23
COMPLETED
NOPARK Open Label Extension StudyNCT05546567 · 2022-09-28
ACTIVE_NOT_RECRUITING
The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood CancerNCT05023993 · 2022-06-23
ACTIVE_NOT_RECRUITING
NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's DiseaseNCT05344404 · 2022-04-29
COMPLETED
Inflammation in COPD and the Effect of Nicotinamide RibosideNCT04990869 · 2021-08-05
COMPLETED
A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's DiseaseNCT03568968 · 2020-05-06
COMPLETED
NR in Chemo-induced Peripheral NeuropathyNCT03642990 · 2019-11-08
TERMINATED
NAD-supplementation in Drug naïve Parkinson's DiseaseNCT03816020 · 2019-03-09
COMPLETED
The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure SubjectsNCT03565328 · 2018-09-27
TERMINATED

Trial status mix

COMPLETED5
RECRUITING3
ACTIVE_NOT_RECRUITING2
TERMINATED2

Phase mix

NA6
PHASE25
PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.